Brief: Athira Pharma Q3 EPS USD -0.75

LeonaBio

07/11/2024 21:05

Nov 07 (Reuters) - Athira Pharma Q3 operating expenses USD 29.621 million.
* Q3 net income USD -28.741 million
* Q3 operating income USD -29.621 million